These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28137763)

  • 21. Increased expression of IL-28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Cheng YY; Sheng YJ; Chang Y; Lin Y; Zhu ZW; Wen LL; Yang C; Liu L; Yang LL; Zhou FS; Zheng XD; Yin XY; Zhang SQ; Cui Y; Yang S; Zhang XJ
    Clin Rheumatol; 2015 Oct; 34(10):1807-11. PubMed ID: 25911176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    Feng Y
    Hokkaido Igaku Zasshi; 1997 Jul; 72(4):443-55. PubMed ID: 9266252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression and clinical significance of different forms of Mer receptor tyrosine kinase in systemic lupus erythematosus.
    Zhu H; Sun X; Zhu L; Hu F; Shi L; Li Z; Su Y
    J Immunol Res; 2014; 2014():431896. PubMed ID: 24741600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus.
    Kristjansdottir H; Steinsson K; Gunnarsson I; Gröndal G; Erlendsson K; Alarcón-Riquelme ME
    Arthritis Rheum; 2010 Jun; 62(6):1702-11. PubMed ID: 20178125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
    Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
    Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased UBASH3A mRNA Expression Levels in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus.
    Liu J; Ni J; Li LJ; Leng RX; Pan HF; Ye DQ
    Inflammation; 2015 Oct; 38(5):1903-10. PubMed ID: 25876712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of CD16- monocyte subsets in systemic lupus erythematous patients.
    Wu Z; Zhang S; Zhao L; Fei Y; Wang L; Li J; Wen X; Zeng X; Zhang F; Li Y
    Clin Rheumatol; 2017 Oct; 36(10):2281-2287. PubMed ID: 28821990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.
    Ali SR; Fong JJ; Carlin AF; Busch TD; Linden R; Angata T; Areschoug T; Parast M; Varki N; Murray J; Nizet V; Varki A
    J Exp Med; 2014 Jun; 211(6):1231-42. PubMed ID: 24799499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis.
    Vazgiourakis VM; Zervou MI; Choulaki C; Bertsias G; Melissourgaki M; Yilmaz N; Sidiropoulos P; Plant D; Trouw LA; Toes RE; Kardassis D; Yavuz S; Boumpas DT; Goulielmos GN
    Ann Rheum Dis; 2011 Dec; 70(12):2184-90. PubMed ID: 21914625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation.
    Angata T; Ishii T; Motegi T; Oka R; Taylor RE; Soto PC; Chang YC; Secundino I; Gao CX; Ohtsubo K; Kitazume S; Nizet V; Varki A; Gemma A; Kida K; Taniguchi N
    Cell Mol Life Sci; 2013 Sep; 70(17):3199-210. PubMed ID: 23519826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population.
    Mu R; Sun XY; Lim LT; Xu CH; Dai CX; Su Y; Jia RL; Li ZG
    Chin Med J (Engl); 2012 Aug; 125(16):2873-7. PubMed ID: 22932083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the impairment of the uptake of apoptotic polymorphonuclear cells by monocyte subpopulations in systemic lupus erythematosus.
    Mikołajczyk TP; Skiba D; Batko B; Krezelok M; Wilk G; Osmenda G; Pryjma JR; Guzik TJ
    Lupus; 2014 Nov; 23(13):1358-69. PubMed ID: 24969081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
    Lin LH; Ling P; Liu MF
    J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased mRNA expression levels of DNA methyltransferases type 1 and 3A in systemic lupus erythematosus.
    Nawrocki MJ; Majewski D; Puszczewicz M; Jagodziński PP
    Rheumatol Int; 2017 May; 37(5):775-783. PubMed ID: 28349196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficiency of IRE1 and PERK signal pathways in systemic lupus erythematosus.
    Wang J; Cheng Q; Wang X; Zu B; Xu J; Xu Y; Zuo X; Shen Y; Wang J; Shen Y
    Am J Med Sci; 2014 Dec; 348(6):465-73. PubMed ID: 25226532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
    Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
    Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.